This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bach, P. H. Articles by Thanh, N. T. K. Search for Related Content PubMed PubMed Citation Articles by Bach, P. H. Articles by Thanh, N. T. K. Social Bookmarking                         What's this?

Renal Papillary Necrosis—40 Years On

BioMedical Research Centre, Division of Biomedical Sciences, Sheffield Hallam University, Sheffield SI 1WB, England, United Kingdom

Nguyen Thi Kim Thanh

BioMedical Research Centre, Division of Biomedical Sciences, Sheffield Hallam University, Sheffield SI 1WB, England, United Kingdom

Analgesics and nonsteroidal anti-inflammatory drugs (NSAIDs) are well recognized as a major class of therapeutic agent that causes renal papillary necrosis (RPN). Over the last decade a broad spectrum of other therapeutic agents and many chemicals have also been reported that have the potential to cause this lesion in animals and man. There is consensus that RPN is the primary lesion that can progress to cortical degeneration; and it is only at this stage that the lesion is easily diagnosed. In the absence of sensitive and selective noninvasive biomarkers of RPN there is still no clear indication of which compound, under what circumstances, has the greatest potential to cause this lesion in man. Attempts to mimic RPN in rodents using analgesics and NSAIDs have not provided robust models of the lesion. Thus, much of the research has concentrated on those compounds that cause an acute or subacute RPN as the basis by which to study the pathogenesis of the lesion. Based on the mechanistic understanding gleaned from these model compounds it has been possible to transpose an understanding of the underlying processes to the analgesics and NSAIDs. The mechanism of RPN is still controversial. There are data that support microvascular changes and local ischemic injury as the underlying cause. Alternatively, several model papillotoxins, some analgesics, and NSAIDs target selectively for the medullary interstitial cells, which is the earliest reported aberration, after which there are a series of degenerative processes affecting other renal cell types. Many papillotoxins have the potential to undergo prostaglandin hydroperoxidase-mediated metabolic activation, specifically in the renal medullary interstitial cells. These reactive intermediates, in the presence of large quantities of polyunsaturated lipid droplets, result in localized and selective injury of the medullary interstitial cells. These highly differentiated cells do not repair, and it is generally accepted that continuing insult to these cells will result in their progressive erosion. The loss of these cells is thought to be central to the degenerative cascade that affects the cortex. There is still a need to understand better the primary mechanism and the secondary consequences of RPN so that the risk of chemical agents in use and novel molecules can be fully assessed.

Key Words: Analgesic nephropathy • renal papillary necrosis • nonsteroidal anti-inflammatory drugs

Toxicologic Pathology, Vol. 26, No. 1, 73-91 (1998)
DOI: 10.1177/019262339802600110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y.-X. J Wang and S.-X. Yan Biomedical imaging in the safety evaluation of new drugs Lab Anim, October 1, 2008; 42(4): 433 - 441. [Abstract] [Full Text] [PDF]

				Y.-X. J Wang, G. Betton, E. Floettmann, and C. Liess MRI histopathology correlation of N-phenylanthranilic acid induced nephropathy in rats Br. J. Radiol., December 1, 2006; 79(948): 1009 - 1010. [Full Text] [PDF]

				Y. Tsuchiya, K. Yabe, S. Takada, Y. Ishii, T. Jindo, K. Furuhama, and K. T. Suzuki Early Pathophysiological Features in Canine Renal Papillary Necrosis Induced by Nefiracetam Toxicol Pathol, August 1, 2005; 33(5): 561 - 569. [Abstract] [Full Text] [PDF]

				N. I. Dmitrieva, Q. Cai, and M. B. Burg Cells adapted to high NaCl have many DNA breaks and impaired DNA repair both in cell culture and in vivo PNAS, February 24, 2004; 101(8): 2317 - 2322. [Abstract] [Full Text] [PDF]

				R. Rao, C.-M. Hao, and M. D. Breyer Hypertonic Stress Activates Glycogen Synthase Kinase 3{beta}-mediated Apoptosis of Renal Medullary Interstitial Cells, Suppressing an NF{kappa}B-driven Cyclooxygenase-2-dependent Survival Pathway J. Biol. Chem., February 6, 2004; 279(6): 3949 - 3955. [Abstract] [Full Text] [PDF]

				A. E. Brix Renal Papillary Necrosis Toxicol Pathol, October 1, 2002; 30(6): 672 - 674. [Abstract] [PDF]

				C.-M. Hao, R. Redha, J. Morrow, and M. D. Breyer Peroxisome Proliferator-activated Receptor delta Activation Promotes Cell Survival following Hypertonic Stress J. Biol. Chem., June 7, 2002; 277(24): 21341 - 21345. [Abstract] [Full Text] [PDF]

				R. C. Harris and M. D. Breyer Physiological regulation of cyclooxygenase-2 in the kidney Am J Physiol Renal Physiol, July 1, 2001; 281(1): F1 - F11. [Abstract] [Full Text] [PDF]

				M. W. Leach, D. W. Frank, M. R. Berardi, E. W. Evans, R. C. Johnson, D. G. Schuessler, E. Radwanski, and M. E. Cartwright Renal Changes Associated with Naproxen Sodium Administration in Cynomolgus Monkeys Toxicol Pathol, May 1, 1999; 27(3): 295 - 306. [Abstract] [PDF]

				L.R. Silverman and K.N.M. Khan "Have You Seen This?" Nonsteroidal Anti-inflammatory Drug-Induced Renal Papillary Necrosis in a Dog Toxicol Pathol, March 1, 1999; 27(2): 244 - 245. [PDF]